GeneDx Holdings WGS Operating Income
Discontinued — last reported Q1 '26
Operating Income at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's operating income?
- GeneDx Holdings (WGS) reported operating income of -$57.47M in Q1 2026.
- How has GeneDx Holdings's operating income changed year-over-year?
- GeneDx Holdings's operating income decreased by 1162.8% year-over-year, from -$4.55M to -$57.47M.
- What is the long-term trend for GeneDx Holdings's operating income?
- Over 3 years (2021 to 2025), GeneDx Holdings's operating income has grown at a -69.2% compound annual growth rate (CAGR), from -$446.15M to -$13.08M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.